ANIK Filings — Anika Therapeutics, Inc. - FilingSpy
ANIK
Anika Therapeutics, Inc.
A maker of joint-preservation and tissue-repair products built on hyaluronic acid — the same slippery substance that naturally cushions human joints. Its injectable treatments Orthovisc, Monovisc, and CINGAL ease osteoarthritis knee pain, while its surgical implants help regenerate torn tendons. Formed in 1992 as a spin-off of MedChem Products, this Bedford, Massachusetts company's products were long sold in the US under the Johnson & Johnson brand rather than its own name.
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +17.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.